Q3 2024 saw improved sales and cash flow, but continued losses and lower nine-month revenue year-over-year. Strategic launches and new agreements in AirCare and HealthCare are driving growth, with financing secured for the next year.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.